# Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study

> **NCT00449085** · PHASE2 · WITHDRAWN · sponsor: **Biosense Webster, Inc.**

## Conditions studied

- Cardiac Arrhythmias

## Interventions

- **PROCEDURE:** Electrophysiology
- **DEVICE:** CARTO™ XP EP Navigation System V9

## Key facts

- **NCT ID:** NCT00449085
- **Lead sponsor:** Biosense Webster, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-04
- **Primary completion:** 2012-07
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2025-02-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00449085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00449085, "Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00449085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*